EA200700834A1 - Рецептура геля с 4-гидрокситамоксифеном - Google Patents

Рецептура геля с 4-гидрокситамоксифеном

Info

Publication number
EA200700834A1
EA200700834A1 EA200700834A EA200700834A EA200700834A1 EA 200700834 A1 EA200700834 A1 EA 200700834A1 EA 200700834 A EA200700834 A EA 200700834A EA 200700834 A EA200700834 A EA 200700834A EA 200700834 A1 EA200700834 A1 EA 200700834A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydroxytamoxifen
gel recipe
recipe
gel
gels
Prior art date
Application number
EA200700834A
Other languages
English (en)
Other versions
EA011295B1 (ru
Inventor
Валери Мазини-Этев
Original Assignee
Лаборатуар Безен Энтернасьональ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292447A external-priority patent/EP1647271A1/en
Application filed by Лаборатуар Безен Энтернасьональ filed Critical Лаборатуар Безен Энтернасьональ
Publication of EA200700834A1 publication Critical patent/EA200700834A1/ru
Publication of EA011295B1 publication Critical patent/EA011295B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям и гелям, включающим 4-гидрокситамоксифен, и к способам их применения.
EA200700834A 2004-10-14 2005-10-13 Рецептура геля с 4-гидрокситамоксифеном EA011295B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292447A EP1647271A1 (en) 2004-10-14 2004-10-14 4-Hydroxy tamoxifen gel formulations
US63835904P 2004-12-23 2004-12-23
PCT/EP2005/011654 WO2006040196A1 (en) 2004-10-14 2005-10-13 4-hydroxy tamoxifen gel formulations

Publications (2)

Publication Number Publication Date
EA200700834A1 true EA200700834A1 (ru) 2007-10-26
EA011295B1 EA011295B1 (ru) 2009-02-27

Family

ID=35501209

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700834A EA011295B1 (ru) 2004-10-14 2005-10-13 Рецептура геля с 4-гидрокситамоксифеном

Country Status (24)

Country Link
EP (1) EP1799201B1 (ru)
JP (1) JP5047800B2 (ru)
KR (1) KR101294947B1 (ru)
AT (1) ATE415156T1 (ru)
AU (1) AU2005293712B2 (ru)
BR (1) BRPI0518139B1 (ru)
CA (1) CA2582174C (ru)
CY (1) CY1110499T1 (ru)
DE (1) DE602005011314D1 (ru)
DK (1) DK1799201T3 (ru)
EA (1) EA011295B1 (ru)
ES (1) ES2318563T3 (ru)
GE (1) GEP20104889B (ru)
HK (1) HK1103027A1 (ru)
HR (1) HRP20090239T1 (ru)
IL (1) IL182298A (ru)
MA (1) MA28927B1 (ru)
MX (1) MX2007004371A (ru)
NO (1) NO338755B1 (ru)
PL (1) PL1799201T3 (ru)
PT (1) PT1799201E (ru)
SI (1) SI1799201T1 (ru)
TN (1) TNSN07139A1 (ru)
WO (1) WO2006040196A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10080760B2 (en) * 2009-10-27 2018-09-25 Besins Healthcare Luxembourg Sarl Transdermal pharmaceutical compositions comprising active agents
KR101304536B1 (ko) * 2011-06-03 2013-09-24 전남대학교산학협력단 4-하이드록시 타목시펜 유사체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 간질환의 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
SI1572178T1 (sl) * 2002-12-18 2006-10-31 Besins Int Lab Zdravljenje mastalgije s 4-hidroksi-tamoksifenom
AU2003296757A1 (en) * 2002-12-18 2004-07-09 Laboratoires Besins International Reduction of breast density with 4-hydroxy tamoxifen
MXPA05010597A (es) * 2003-04-01 2006-03-09 Lab Besins Internat Prevencion y tratamiento de cancer de mama con tamoxifen 4-hidroxi.
DK1694319T3 (da) * 2003-12-15 2008-11-17 Besins Int Lab Anvendelser af 4-hydroxytamoxifen til fremstilling af et medikament til behandling af gynækomasti
EP1579857A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Chemically stable compositions of 4-hydroxy tamoxifen
AU2005227072B2 (en) * 2004-03-22 2010-08-19 Besins Healthcare Luxembourg Sarl Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen

Also Published As

Publication number Publication date
CA2582174C (en) 2013-01-29
TNSN07139A1 (en) 2008-11-21
MX2007004371A (es) 2007-06-07
BRPI0518139A (pt) 2008-10-28
DK1799201T3 (da) 2009-03-30
HRP20090239T1 (en) 2009-06-30
PL1799201T3 (pl) 2009-05-29
SI1799201T1 (sl) 2009-06-30
AU2005293712A1 (en) 2006-04-20
GEP20104889B (en) 2010-02-10
HK1103027A1 (en) 2007-12-14
PT1799201E (pt) 2009-02-26
IL182298A (en) 2013-01-31
JP5047800B2 (ja) 2012-10-10
CA2582174A1 (en) 2006-04-20
NO338755B1 (no) 2016-10-17
EP1799201A1 (en) 2007-06-27
ES2318563T3 (es) 2009-05-01
NO20072463L (no) 2007-05-14
MA28927B1 (fr) 2007-10-01
IL182298A0 (en) 2007-07-24
CY1110499T1 (el) 2015-04-29
DE602005011314D1 (de) 2009-01-08
EP1799201B1 (en) 2008-11-26
EA011295B1 (ru) 2009-02-27
JP2008525316A (ja) 2008-07-17
AU2005293712B2 (en) 2011-04-21
ATE415156T1 (de) 2008-12-15
KR20070068366A (ko) 2007-06-29
KR101294947B1 (ko) 2013-08-09
BRPI0518139B1 (pt) 2021-10-13
WO2006040196A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
EA200701918A1 (ru) Белок липокалин
SE0301653D0 (sv) Novel compounds
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
ATE528989T1 (de) Kristalline feste rasagilin-base
NO20091976L (no) Nye forbindelser
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
BRPI0516857A (pt) dispositivos biomédicos que contêm copolìmeros de bloco anfifìlico
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201171494A1 (ru) Миметики белка smac
EA200870116A1 (ru) Бициклические гетероарильные соединения
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
EA201100084A1 (ru) Сшиваемая полимерная композиция
EA200602243A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
BRPI0508064A (pt) flavivìrus, composição de vacina e molécula de ácido nucléico
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
NO20055741D0 (no) Nye kjemiske forbindelser
EA201070853A1 (ru) Кристаллический (r)-2-(4-циклопропансульфонилфенил)-n-пиразин-2-ил-3-(тетрагидропиран-4-ил)пропионамид
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
RS53751B1 (en) AGOMELATIN HYDROHALID COMPLEX AND PROCEDURE FOR ITS MAKING
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA200701592A1 (ru) Композиты и способы их получения и использования
EA200801414A1 (ru) Кальцилитические соединения

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment